Safety and Efficacy of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice: Interim Analysis of ESTEEM

被引：0
|
作者：
Everage, Nicholas J. [1 ]
Prada, Claudia [1 ]
Liu, Shifang [1 ]
Balashov, Konstantin [2 ]
Macdonell, Richard [3 ]
Windsheimer, Jorg [4 ]
Giles, Kathryn [5 ]
机构：
[1] Biogen, Cambridge, MA USA
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[3] Univ Melbourne, Austin Hlth, Dept Neurol, Melbourne, Vic, Australia
[4] Praxis Neurol & Psychiat, Nurnberg, Germany
[5] Cambridge Mem Hosp, Cambridge, ON, Canada
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.333
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Safety profile of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: long-term interim results from the ENDORSE extension study
    Pozzilli, C.
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Gold, R.
    JOURNAL OF NEUROLOGY, 2014, 261 : S439 - S439
  • [42] Pregnancy outcomes from an international registry of patients treated with delayed-release dimethyl fumarate
    Everage, N. J.
    Jones, C. C.
    Hellwig, K.
    Rog, D.
    Liu, S.
    Mou, J.
    Prada, C.
    Hanna, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 295 - 295
  • [43] Management Strategies to Facilitate Optimal Outcomes for Patients Treated with Delayed-release Dimethyl Fumarate
    Mayer, Lori
    Fink, Mary Kay
    Sammarco, Carrie
    Laing, Lisa
    DRUG SAFETY, 2018, 41 (04) : 347 - 356
  • [44] Efficacy Of Delayed-release Dimethyl Fumarate In Patients ≥55 Years Enrolled In The RESPOND Study
    Repovic, P.
    Robertson, D.
    Cohan, S. L.
    Mao-Draayer, Y.
    Xiong, K.
    Borowski, J.
    Avila, R.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 31 - 32
  • [45] Safety profile of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: long-term interim results from the ENDORSE extension study
    Pozzilli, C.
    Phillips, J. T.
    Fox, R. J.
    Selmaj, K.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Gold, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 678 - 678
  • [46] Delayed-release dimethyl fumarate safe to use in MS patients
    Reactions Weekly, 2018, 1714 (1) : 6 - 6
  • [47] Efficacy and safety of delayed-release dimethyl fumarate in treatment-naive Japanese patients with relapsing-remitting multiple sclerosis: A post-hoc subgroup analysis of the apex study
    Mori, M.
    Ohashi, T.
    Onizuka, Y.
    Hiramatsu, K.
    Hase, M.
    Yun, J.
    Ling, Y.
    Torii, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 795 - 796
  • [48] PREGNANCY OUTCOMES WITH DELAYED-RELEASE DIMETHYL FUMARATE: INTERIM RESULTS FROM AN INTERNATIONAL REGISTRY
    Everage, Nicholas J.
    Liu, Shifang
    Yun, Jang
    Prada, Claudia
    Hanna, Jerome
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E22 - E22
  • [49] Pregnancy reports and outcomes from multiple sclerosis patients primarily treated with peginterferon beta-1a and delayed-release dimethyl fumarate in Germany
    Niemczyk, G.
    Begus-Nahrmann, Y.
    Herold, S.
    Grundler, M. -T.
    Rosenstroem, H.
    Sedlmeier, R.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 732 - 732
  • [50] The potential of individualized patient coaching to optimize treatment with delayed-release dimethyl fumarate: a retrospective analysis of patients with multiple sclerosis treated in a real-world setting
    Begus-Nahrmann, Y.
    Niemczyk, G.
    Schmid, B.
    Maeurer, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 636 - 637
12345